NCT04641078 Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer Status RECRUITING Phase PHASE2
NCT04558866 Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04484818 Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04335682 Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04319783 Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04176081 Study of Radiation Therapy in Combination With Darolutamide + Degarelix in Intermediate Risk Prostate Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT04136353 Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04025372 INTREPId (INTermediate Risk Erection PreservatIon Trial) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03903835 ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer Status RECRUITING Phase PHASE3
NCT03878524 Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial Status TERMINATED Phase PHASE1
NCT03385655 Prostate Cancer Biomarker Enrichment and Treatment Selection Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03383679 Study on Androgen Receptor and Triple Negative Breast Cancer Status COMPLETED Phase PHASE2
NCT03004534 A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide Status COMPLETED Phase EARLY_PHASE1